CD40 and neoplasm: Recent studies have shown that prophylactic immunization of tumor-bearing mice with tumor antigen-pulsed CD40-activated B cells can induce protective antitumor immunity against B16, leading to reduced growth of F10 melanoma and E.G7 lymphoma [116].